The cure rate for leukemia M2 is not very high and can be cured in a small number of patients. Although leukemia M2 is more severe, its probability of cure is greatly increased with reasonable treatment.
Leukemia can be divided into acute leukemia and chronic leukemia depending on the course of the disease. Acute leukemia can be divided into acute lymphoblastic leukemia (ALL) and acute myeloid leukemia (AML). Acute myeloid leukemia can be typed according to morphology and is divided into 8 types, including M0, M1, M2, M3, M4, M5, M6 and M7. Leukemia M2 is an AML. Leukemia M2 can be subdivided into two subtypes.
Acute leukemia progresses rapidly and without treatment, the average survival is only 3 months, with a few people surviving for a few days.
Acute myeloid leukemia is a malignancy of the myeloid hematopoietic stem cells, most of which are critical, have an aggressive prognosis, and can lead to death if not treated promptly, accounting for 30% of pediatric leukemias. Among these subtypes, leukemia M2 has a relatively good morphology, and although the disease is severe, the cure rate is greatly improved with treatment, such as a successful bone marrow transplant.